Your browser doesn't support javascript.
loading
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.
Matthews, Dawn C; Kinney, Jefferson W; Ritter, Aaron; Andrews, Randolph D; Toledano Strom, Erin N; Lukic, Ana S; Koenig, Lauren N; Revta, Carolyn; Fillit, Howard M; Zhong, Kate; Tousi, Babak; Leverenz, James B; Feldman, Howard H; Cummings, Jeffrey.
  • Matthews DC; ADM Diagnostics, Inc. Northbrook Illinois USA.
  • Kinney JW; Department of Brain Health University of Nevada Las Vegas Las Vegas Nevada USA.
  • Ritter A; Hoag Pickup Family Neurosciences Institute Newport Beach California USA.
  • Andrews RD; ADM Diagnostics, Inc. Northbrook Illinois USA.
  • Toledano Strom EN; Chambers-Grundy Center for Transformative Neuroscience Department of Brain Health School of Integrated Health Sciences, University of Nevada Las Vegas Las Vegas Nevada USA.
  • Lukic AS; ADM Diagnostics, Inc. Northbrook Illinois USA.
  • Koenig LN; ADM Diagnostics, Inc. Northbrook Illinois USA.
  • Revta C; Alzheimer's Disease Cooperative Study University of California, San Diego, School of Medicine La Jolla California USA.
  • Fillit HM; Alzheimer's Drug Discovery Foundation New York New York USA.
  • Zhong K; CNS Innovations LLC Henderson Nevada USA.
  • Tousi B; Cleveland Clinical Lous Ruvo Center for Brain Health Cleveland Ohio USA.
  • Leverenz JB; Neurologic Institute, Cleveland Clinic Cleveland Ohio USA.
  • Feldman HH; Alzheimer's Disease Cooperative Study University of California, San Diego, School of Medicine La Jolla California USA.
  • Cummings J; Department of Neurosciences University of California San Diego La Jolla California USA.
Alzheimers Dement (N Y) ; 10(3): e12490, 2024.
Article en En | MEDLINE | ID: mdl-38988416